Drug development targeting amino acid transporter LAT1 (SLC7A5); development of drugs forbiliary tract cancer and pancreatic cancer is ongoing
Providing new treatment options for many patients suffering from incurable diseases such as biliary tract cancer and pancreatic cancer
Joint research with leading universities in Japan, the University of Colorado (U.S.), the National Science Center in Nice (France), and Khon Kaen University(Thailand), etc.
Company name
J-Pharma Co., Ltd.
Type of business
Medical(medical devices, drug discovery)
Representatives
Masuhiro Yoshitake
Establishing a company
December 2005
Investment announcement date
July 2021
Capitalist
Takuma Tsuzuku
HP
https://www.j-pharma.com/Phasing
Middle to Growth